| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |